Correction for Qiao et al., “A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae”

Correction for Qiao et al., “A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae”

Saved in:

Bibliographic Details
Main Authors:	Sai Qiao, Shaojun Xin, Yufeng Zhu, Feng Zhao, Heng Wu, Jingjing Zhang, Bingyan Yao, Yunsong Yu, Ying Fu, Yan Jiang, Xinyou Xie, Jun Zhang
Format:	Article
Language:	English
Published:	American Society for Microbiology 2024-12-01
Series:	Microbiology Spectrum
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.02569-24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
by: Yingyi Guo, et al.
Published: (2024-10-01)

Evolution of ceftazidime–avibactam resistance driven by mutations in double-copy blaKPC-2 to blaKPC-189 during treatment of ST11 carbapenem-resistant Klebsiella pneumoniae
by: Xiaofan Zhang, et al.
Published: (2024-10-01)

ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam
by: Marta Hernández-García, et al.
Published: (2025-08-01)

Evolution of ceftazidime-avibactam resistance driven by variation in blaKPC-2 to blaKPC-190 during treatment of ST11-K64 hypervirulent Klebsiella pneumoniae
by: Zeshi Liu, et al.
Published: (2025-06-01)

Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae
by: Qingyu Shi, et al.
Published: (2024-12-01)

Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01)

Characterization of Klebsiella pneumoniae carbapenemase (KPC)-14, a KPC variant conferring resistance to ceftazidime-avibactam in the extensively drug-resistant ST463 Pseudomonas aeruginosa clinical isolate
by: Yanyan Xiao, et al.
Published: (2025-05-01)

Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia
by: Yi-Tsung Lin, et al.
Published: (2025-09-01)

In Vitro Efficacy of Ceftazidime-avibactam Against blaOXA-48-producing Klebsiella pneumoniae Isolates
by: Yasemin ÇAĞ, et al.
Published: (2023-11-01)

Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam
by: A. Schimmenti, et al.
Published: (2018-01-01)

Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice
by: Oya Özlem Eren-Kutsoylu, et al.
Published: (2024-07-01)

Whole-genome sequencing characterisation of a new KPC-245 variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam
by: Claudia Vaiana, et al.
Published: (2025-05-01)

Emergence and characterization of IncFII/IncR plasmids with multiple 5,692 bp- blaKPC−2-bearing tandem repeats in ceftazidime/avibactam non-susceptible Klebsiella pneumoniae strains
by: Hongmao Liu, et al.
Published: (2025-04-01)

Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
by: Jingli Lu, et al.
Published: (2025-01-01)

Diverse modes of ceftazidime/avibactam resistance acquisition in carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa from a Chinese intensive care unit
by: Junxin Zhou, et al.
Published: (2025-05-01)

In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
by: Siquan Shen, et al.
Published: (2024-12-01)

Effectiveness of ceftazidime/avibactam as a continuous infusion in critically ill patients with OXA-48-producing Klebsiella pneumoniae infection
by: Ivan Šitum, et al.
Published: (2024-06-01)

In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512
by: Valerio Capitani, et al.
Published: (2024-09-01)

Study on the invitro synergistic susceptibility and biofilm inhibition mechanism of ceftazidime-avibactam combined with aztreonam against carbapenem-resistant Klebsiella pneumoniae
by: Guangfen Wang, et al.
Published: (2025-03-01)

Carbapenem-resistant Klebsiella pneumoniae infections in Chinese children: in vitro activities of ceftazidime-avibactam and aztreonam-avibactam against carbapenemase-producing strains in a two-center study
by: Xia Ran, et al.
Published: (2025-03-01)

Overexpression of blaSHV-12 caused by tandem amplification contributed to ceftazidime/avibactam resistance in hypervirulent and carbapenem-resistant Klebsiella pneumoniae
by: Chao Liu, et al.
Published: (2024-12-01)

Genomic and molecular characterization of a ceftazidime-avibactam resistant Klebsiella pneumoniae strain isolated from a Chinese tertiary hospital
by: Yanye Tu, et al.
Published: (2025-04-01)

Dissemination of extensively drug-resistant and KPC-2 producing Klebsiella pneumoniae isolated from bloodstream infections
by: Feng Zhao, et al.
Published: (2015-09-01)

Treatment of pediatric central nervous system infection caused by carbapenem-resistant Klebsiella pneumoniae with ceftazidime/avibactam, two cases report and literature review
by: Lu Qing, et al.
Published: (2025-02-01)

Emergence of Tigecycline-Nonsusceptible Carbapenem-Resistant <i>Klebsiella pneumoniae</i> with Metallo-β-Lactamase and Transferable Ceftazidime-Avibactam Resistance in China
by: Yajuan Ni, et al.
Published: (2025-03-01)

Retrospective Tertiary Care-Based Cohort Study on Clinical Characteristics and Outcomes of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Fatema Ahmed, et al.
Published: (2024-01-01)

Evaluating the susceptibility to ceftazidime-avibactam in clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa recovered from an apex medical hospital in north India
by: Nargis Bali, et al.
Published: (2025-04-01)

The Impact Of Ceftazidime-Avibactam Utilization In Hospital Setting
by: Shobana Selvaganesan, et al.
Published: (2024-12-01)

Identification of two KPC variants, KPC-204 and KPC-227, in ST11-K64 Klebsiella pneumoniae during prolonged hospitalization of a single patient
by: Shijun Sun, et al.
Published: (2025-06-01)

Effectiveness and safety of ceftazidime-avibactam in Chinese patients with hospital-acquired pneumonia, including ventilator-associated pneumonia: A Phase 4, multi-centre, open-label study
by: Jinyi Yuan, et al.
Published: (2025-06-01)

Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
by: Congcong Liu, et al.
Published: (2025-01-01)

Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022
by: Xi Li, et al.
Published: (2024-12-01)

Pathogenicity of Klebsiella pneumonia (KpC4) infecting maize and mice
by: Min HUANG, et al.
Published: (2016-07-01)

Tracking international and regional dissemination of the KPC/NDM co-producing Klebsiella pneumoniae
by: Feilong Zhang, et al.
Published: (2025-07-01)

Safety and Efficacy of Ceftazidime/Avibactam in the Treatment of Severe Neonatal Infections
by: Mi Zhou, et al.
Published: (2024-12-01)

Investigating Gram-negative bacilli isolates’ sensitivity to ceftazidime/avibactam
by: Sunali, et al.
Published: (2025-01-01)

Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia
by: Jessica Matuoka, et al.
Published: (2025-07-01)

In vitro susceptibility of Burkholderia cepacia to ceftazidime-avibactam: A systematic review
by: Abolfazl Rafati Zomorodi, et al.
Published: (2025-08-01)

Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children
by: Wilson Toyohiro Hoshino, et al.
Published: (2025-03-01)

Ertapenem+Meropenem Including Double Carbapenem Therapy (EMDCT) Versus Ceftazidime-Avibactam Therapy In The Therapy Of Carbapenem-Resistant Klebsiella Pneumoniae Infections (CRKPI): A Retrospective Matched Cohort Study
by: Merve Mert Vahabi, et al.
Published: (2024-12-01)